Amanda Bonham
Adult Health · Cleveland, OHNPI 1629449244
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Pfizer at 52.2% of the total. Reporting peaked in 2024 at $4,584 and has fallen 84.3% since, to $721 in 2025. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $142.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$4K
- Bayer$626
- E.r. Squibb & Sons, L.L.C.$512
- Johnson & Johnson$445
- Seagen Inc.$437
- AstraZeneca$305
- plus $1K from 12 others
What the payments were for
- Consulting fees$2,08528%
- Travel & lodging$1,49020%
- Food & beverage$3,44846%
- Education$4015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $3,878 |
| Bayer | 8 | $626 |
| E.r. Squibb & Sons, L.L.C. | 5 | $512 |
| Johnson & Johnson | 5 | $445 |
| Seagen Inc. | 4 | $437 |
| AstraZeneca | 4 | $305 |
| Incyte Corporation | 2 | $215 |
| Novartis | 3 | $176 |
| G1 Therapeutics, Inc. | 1 | $121 |
| Astellas Pharma US Inc | 2 | $116 |
| Servier Pharmaceuticals LLC | 1 | $110 |
| Beigene USA, Inc. | 1 | $105 |
| Exelixis Inc. | 1 | $103 |
| AVEO Pharmaceuticals, Inc. | 1 | $92 |
| Merck | 3 | $81 |
| Pharmacosmos Therapeutics Inc. | 1 | $48 |
| Adaptive Biotechnologies Corporation | 1 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,423 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 107 | $1,012,504 |
| XtandiEnzalutamide | 67 | $701,519 |
| Abiraterone Acetate | 126 | $206,704 |
| OrgovyxRelugolix | 13 | $34,069 |
| EliquisApixaban | 23 | $17,960 |
| Ondansetron Hcl | 35 | $1,597 |
| Potassium Chloride | 55 | $886 |
| Bicalutamide | 11 | $880 |
| Prednisone | 196 | $823 |
| Olanzapine | 32 | $470 |
| Levothyroxine Sodium | 70 | $385 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 45 | $383 |
| Dexamethasone | 16 | $370 |
| Tamsulosin Hcl | 46 | $338 |
| Prochlorperazine Maleate | 17 | $186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $445 | $1,012,504107 claims |
| Astellas Pharma US IncXtandi | $116 | $701,51967 claims |
| PfizerEliquis | $3,878 | $17,96023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,184 adult health providers in Ohio.
Other adult health in Cleveland
- Susan FlickCleveland$131K
- Kathleen HarrisCleveland$28K
- Margaret TiktinCleveland$22K
- Mindy RiveraCleveland$20K
- Elizabeth CrespoCleveland$12K
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.